We are live on ! Find out more
HCCCU

Healthcare Capital Corp. Unit

Delisted

HCCCU was delisted on the 7th of March, 2022.

11 hedge funds and large institutions have $3.1M invested in Healthcare Capital Corp. Unit in 2021 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

42% less funds holding

Funds holding: 1911 (-8)

80% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 10

89% less capital invested

Capital invested by funds: $27.3M → $3.1M (-$24.2M)

Holders
11
Holders Change
-8
Holders Change %
-42.11%
% of All Funds
0.17%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
2
Reduced
Closed
10
Calls
Puts
Net Calls
Net Calls Change

HCCCU Hedge Fund Activity: Q4 2021 in Review

11 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Healthcare Capital Corp. Unit (HCCCU) for Q4 2021, worth a combined $3.1M — down 89% from $27.3M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of HCCCU and 2 opened new positions — a net loss of 8 holders — while 0 trimmed existing stakes and 2 added.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $110K. The largest seller was BlueCrest Capital Management, exiting entirely with an estimated $18.4M sold.

  • 11 institutional investors held Healthcare Capital Corp. Unit (HCCCU) as of Q4 2021, down from 19 in Q3 2021.
  • Funds reported $3.1M of Healthcare Capital Corp. Unit stock for Q4 2021, down 89% quarter-over-quarter.
  • 2 funds opened new Healthcare Capital Corp. Unit positions in Q4 2021 and 10 closed out, a net change of -8 holders.
  • The largest Healthcare Capital Corp. Unit buyer in Q4 2021 was Citadel Advisors, an estimated $110K added.
  • The largest Healthcare Capital Corp. Unit seller in Q4 2021 was BlueCrest Capital Management, an estimated $18.4M sold.

Based on aggregated 13F filings for Q4 2021.